Hongwei Shi

机构：Hubei Cancer Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-8760-4733

发表论文 61 篇 · 总被引 506 次 · h-index 10

代表论文

• Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis (2021 · Frontiers in Pharmacology · 被引 43)
• Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin‐Induced Hepatotoxicity (2022 · BioMed Research International · 被引 25)
• Late-stage conversion of carboxylic acids to nitriles with Mg and Pd cocatalysis (2025 · Nature Catalysis · 被引 11)
• Research Progress on Flavonoids in Traditional Chinese Medicine to Counteract Cardiotoxicity Associated with Anti-Tumor Drugs (2024 · Reviews in Cardiovascular Medicine · 被引 9)
• Asprosin contributes to vascular remodeling in hypertensive rats via superoxide signaling (2024 · Journal of Hypertension · 被引 8)
• Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma (2024 · World Journal of Gastroenterology · 被引 5)